“showed a trend”

33.9%, p = 0.040) and showed a trend toward increased stimulant use (62.5% vs. 39%, p = 0.051).

Participants did not increase positive affect after compared to before the experiment ( Figure 2 A, Table S1 ; PANAS-P, before: 56.4 ± 12.4, after: 56.7 ± 13.4, paired one-tailed t-test, t 19 = 0.13, p = 0.89), but showed a trend decrease in negative affect (PANAS-N, before: 20.5 ± 3.1, after: 19.4 ± 2.3, paired one-tailed t-test, t 19 = 1.72, p = 0.051).

Interestingly the co-culture group showed a trend of upregulation of the basal-specific epidermal marker KRT14 with 0.4 folds over the 100% group ( p -value = 0.051; Figure 2 g) while it kept the same upregulation pattern in comparison to the 0% group ( p -value = 0.0005; Figure 2 g).

The reduction of macrophages also showed a trend for predicting clinical improvement at week 24 in the univariate analysis (p = 0.051), but when analysed together with the decrease in plasma cells in a multiple linear regression model, it was not an independent predictor of the decrease in DAS28 (p = 0.216, partial correlation 0.399).

Specifically, patients with hypomethylation showed a trend toward more frequent foot amputations (43.9% versus 27.6%; p = 0.051).

The interaction term group × direction showed a trend (p = .051, using Pillai’s trace V = .337, F(4,22) = 2.80).

Three-back accuracy was significantly improved in individuals with EOS ( Z = −2.157, p = 0.031), whereas typically developing adolescents showed a trend of accuracy improvement ( Z = −1.949, p = 0.051) ( Table 1 ).

In addition, pre-menopausal women with obesity showed a significantly higher chance to have an intermediate chronotype (OR = 2.21, 95% CI 1.28–3.83; p = 0.004), whereas post-menopausal women with obesity showed a trend to have a higher morning chronotype (OR = 1.42, 95% CI 0.98–2.06; p = 0.051), although this did not reach statistical significance.

Compared to SSc-NCFS patients (0.47), SSc-CFS patients showed a trend of reduced expression of ND4 (0.34, p = 0.051) ( Figure 1 A).

After adjustment, higher preoperative PVR (adjusted OR 1.25 per 1 WU increase, 95% CI 1.03–1.52, p = 0.024), higher LAS (adjusted OR 1.06 per 1-point increase, 95% CI 1.04–1.08, p < 0.0001), and higher intraoperative mPAP (adjusted OR 1.1 per 1 mmHg increase, 95% CI 1.05–1.16, p < 0.0001) remained independently associated with intraoperative MCS use, while right-sided transplant showed a trend toward independent association (adjusted OR 2.26, 95% CI 0.996–5.107, p = 0.051).

The predicted therapeutic benefits of EVT also showed a trend towards increasing as NIHSS scores increased ( p = 0.051 for the linear trend test of ORs).

Log TILL showed a trend to be higher in the amnestic VCI group versus normal cognition (mean difference 0.709, 95% CI −0.003–1.421, SE 0.2995, P = 0.051).

The number of recurrences showed a trend for an association with additional resection ( p = 0.051).

The analyses of number of reinforcers collected showed a trend for a main effect of exposure, F(3,25) = 3.0; p = 0.051 .

1 l); the DI was significantly greater than 0 in Septin5 +/+ mice (one-sample t test, p = 0.022) and showed a trend in Septin5 −/− mice ( p = 0.051), and no significant genotype differences were observed in either the preference index or DI (Fig. 1 l).

Multivariate analysis showed a trend of HCC recurrence ( p = 0.051, HR: 1.45).

Nevertheless, patients with high‐risk cytogenetics showed a trend toward lower 3‐year PFS than those without (77.8% vs. 89.4%, p = 0.051), and ultra‐high‐risk cytogenetics (≥2 high‐risk cytogenetics) had an even worse prognosis, with 61.2% 3‐year PFS.

Darker-skinned individuals were higher in colour saturation (fair-skinned 33.83 + / − 0.85, dark-skinned: 37.76 + / − 2.83, t = 5.92, df = 10, p < .001, d = 2.53) and showed a trend to be lower in colour value (fair-skinned 74.87 + / − 1.75, dark-skinned: 73.37 + / − 2.46, t = 2.25, df = 10, p = .051, d = 0.64).

Univariate analysis for overall survival revealed that those patients at the S 2–3 stage and those receiving second-line therapies showed a trend of having an increased death risk (hazard ratio [HR] = 8.26, 95% confidence interval (CI), 0.99-68.67, p = 0.051; HR = 7.76, 95% CI, 0.93-64.99, p = 0.059, respectively).

This phenomenon showed a trend to become significant with time (F (6,282) = 2.131, p = 0.051).

Among these patients, Cys C was significantly decreased in follow-up period [1.01 (0.81-1.31) mg/L versus 0.97 (0.69-1.20) mg/L, p = 0.017] whereas estimated GFR showed a trend to increase (p = 0.051) (Table 3 ).

The abundance of Sneathia sanguinegens in untreated patients was also higher than in controls, and this difference showed a trend toward statistical significance ( p = 0.051).

In both univariate and multivariate analyses, BMI did not show a statistically significant independent effect, although a higher BMI showed a trend toward increased risk of complications (hazard ratio [HR], 1.076; 95% confidence interval [CI], 1.000–1.158; p = 0.051).

Considering demographic characteristics, age was the only significant external factor inversely associated with the Perceived Ease of Use in COPD (rho = −0.436, p = 0.010), and showed a trend with Perceived Ease of Use in PD (rho = −0.293, p = 0.051).

Moreover, the proportion of detected spines in MEC with filopodial morphology was negatively correlated with SD interventions required ( Figure 3 , bottom; Pearson’s r = −0.94, p < .05), while the proportion with stubby morphology showed a trend for positive correlation with SD interventions (Pearson’s r = 0.88, p = .051).